Select Committee on China

“China is the sole supplier of at least one key starting material for 37% of all U.S. approved medicines.” In testimony before Congress, @US_Antibiotics's Patrick Cashman warned that America’s drug supply chain is far more dependent on China than most realize. From antibiotics to essential medicines, this concentration creates serious vulnerabilities for both public health and national security.

At yesterday’s @ChinaSelect hearing, Chairman @RepMoolenaar warned that China is cornering the U.S. medicine market, from generic drugs to the cutting-edge biotech pipeline. Today, that warning was made real: a Chinese researcher at @UTMDAnderson tried to smuggle NIH- and DoD-funded cancer research to China. This is exactly the type of threat the Select Committee is addressing. Our national security depends on protecting American medicine. houstonchronicle.com/news/houston-t…

The rise of China’s global manufacturing footprint comes with serious costs. A new report details allegations of forced labor, passport confiscation, and inhumane conditions tied to @BYDCompany's flagship project in Brazil. This case highlights the risks when transparency and labor protections are ignored in global supply chains tied to China. washingtonpost.com/world/2026/03/…

America’s drug supply chain is more fragile than it looks. For everyday medicines, @BrookingsEcon Dr. Marta Wosinska argues “friend-shoring” with allies may be the most effective way to reduce reliance on China. “The smart path is to reserve full end-to-end onshoring for critical drugs.”

WATCH | @StrandTx's Dr. Jacob Becraft warns, "a future where we hand control to China over the discovery, development and manufacturing of the medicines we rely on is truly not far away.” The race for clinical data is the race for global leadership.

@JTLonsdale @8vc x.com/ChinaSelect/st…

My @8VC partner Francisco is giving key testimony today about CCP crushing our ability to develop cures. China has legit innovators - but also a culture of stealing, and working around patents. Our legacy FDA is so slow that they can copy and get to market faster. Let’s fix it.

💊 “Without bold action, we face an existential threat to one of the greatest innovation engines in human history.” – @8vc's Dr. Francisco Gimenez warns Congress that China is already disrupting U.S. biotech. 📈 From $3.2T in economic output to 10M jobs supported, the stakes couldn’t be higher.

WATCH | @RepGusBilirakis shares how the American Made Medicines Caucus is tackling foreign influence and investing in domestic biopharmaceutical manufacturing.

WATCH | Rep. @ZachNunn: "I've been on the front lines as a counterintelligence officer fighting against China for over the last two decades. And I think we all recognize when China starts to dominate in any sector... it becomes an unfair advantage they gain, particularly when it comes to healthcare and biotech."

WATCH | @RepNateMoran sounds the alarm: China now conducts more clinical trials than the U.S., dominates key drug ingredients, and could surpass America in life-saving medicine innovation.

WATCH | @RepAshleyHinson pushes for stronger U.S. drug supply chains and faster clinical trials. Protecting patients, supporting American biotech, and keeping our medicine here at home!

WATCH | @RepLaHood questions biotech leaders on how China is cornering the medicine market and what it means for patients and national security. "China’s rapid advancements in biotechnology are challenging America’s leadership. We must ensure life-saving innovation starts and stays here in the U.S., for the sake of patients and national security."

WATCH | @RepNewhouse questions experts on the 2022–23 amoxicillin shortage and what the federal government can do to prevent future crises. 💊

WATCH | @DrNealDunnFL2 : “We’ve handed the Chinese Communist Party the instrument tray.” 90% of generics rely on Chinese APIs. This is a medical AND national security crisis.

China’s rapid advancements in biotechnology are increasingly concerning. America’s leadership in developing cutting-edge, life-saving pharmaceuticals must continue. I appreciate Strand Therapeutics CEO and Metamora native Dr. Jacob Becraft for testifying at today’s @ChinaSelect hearing about how we can better utilize our clinical infrastructure to strengthen US leadership in pharmaceutical innovation and ensure patients have access to next generation treatments.

WATCH | Chairman @RepMoolenaar questions experts on how China now controls nearly 50% of global pharmaceutical deals. Early-stage drug development is at risk, and Congress must act NOW to protect American innovation. @StrandTx's Dr. Jacob Becraft: "China today is the best at running from idea to dosing a first in human and getting that critical early stage first in human data."

OPENING STATEMENT | Chairman @RepMoolenaar opened our @ChinaSelect hearing today with a stark warning about America's pharmaceutical future: "China is cornering the market on our medicines — from the supply of generic drugs that Americans depend on every day, to the cutting-edge biotech pipeline that will determine who leads medicine in the years and decades ahead."

From the Science Lab to the Medicine Cabinet: How China is Cornering the Market on Our Medicines 03-18-26 x.com/i/broadcasts/1…

At #CND69, America led the world, and China stood alone. The U.S. secured adoption of a historic resolution to crack down on illicit drug supply chains and stop traffickers from exploiting global commerce. Only one country voted NO: China. As @ChinaSelect has exposed, the CCP continues to fuel the fentanyl crisis through precursor production and weak enforcement. We will keep fighting to choke off these deadly flows and protect American lives. 🇺🇸 chinaselectcommittee.house.gov/media/investig…

Filling out your March Madness bracket? Here are the universities in the tournament that have joint institutes with Chinese universities that pose a serious national security risk. Men’s Tournament @UArkansas, @DukeU, @universityofga, @UHouston, @uidaho, @northerniowa, @TSUedu, and @USUAggies Women’s Tournament Duke, Georgia, Idaho, @UMNews, and @virginia_tech All universities should end these partnerships and protect our country. More on our report here: chinaselectcommittee.house.gov/media/reports/…